PLATINUM INVESTMENT MANAGEMENT LTD — 13F Holdings & Portfolio

CIK 1256071 · latest 13F-HR filed 2026-08-13

PLATINUM INVESTMENT MANAGEMENT LTD manages $406.7M in 13F-reported U.S. long-equity assets across 85 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are ZTO (10.97%), MU (5.05%), LRCX (4.95%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 10 new positions and exited 14; 39 existing positions rose in reported value and 24 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$406.7M

Long-equity book

Holdings
85

Distinct positions

Period
2026-06-30

Filed 2026-08-13

Q/Q Activity
+10 / −14 / ↑39 / ↓24

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 38.9%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People
Assets Under Management
$5.04B
Discretionary
$5.04B
Employees
82
Accounts
14
Address
LEVEL 8, 7 MACQUARIE PLACE
SYDNEY NSW 2000
Australia
Phone
61 2 9255 7574
Name Title / Status Ownership Type
ANNAEUS PTY LTD ControlTRUSTEEGeneral partnerForeign Entity
L1 GROUP LIMITED ControlSHAREHOLDER75% or moreForeign Entity
LAMM FM FAMILY TRUST ControlSHAREHOLDER25–50%Foreign Entity
LAMM, RAPHAEL ControlSHAREHOLDER75% or moreIndividual
LANDAU, MARK, PHILIP ControlSHAREHOLDER75% or moreIndividual
MARK LANDAU FAMILY TRUST ControlSHAREHOLDER25–50%Foreign Entity
PETERS, JEFFREY, FRANKLIN ControlDIRECTORLess than 5%Individual
PLATINUM ASSET PTY LIMITED ControlHOLDING COMPANY75% or moreForeign Entity
SHOMRON PTY LTD ControlTRUSTEEGeneral partnerForeign Entity
STEWART, JANE, ELIZABETH ControlCHIEF COMPLIANCE OFFICERLess than 5%Individual
Sidoti, Robert, John ControlDIRECTORLess than 5%Individual
Stannard, Andrew, Norman ControlDIRECTORLess than 5%Individual

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

PLATINUM INVESTMENT MANAGEMENT LTD Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ZTO EXPRESS CAYMAN INC ZTO 98980A105 $44.6M 10.97% 1,994,127 SH
2 MICRON TECHNOLOGY INC MU 595112103 $20.5M 5.05% 17,782 SH
3 LAM RESEARCH CORP LRCX 512807306 $20.1M 4.95% 46,439 SH
4 TRIP COM GROUP LTD TCOM 89677Q107 $14.0M 3.45% 351,921 SH
5 DINGDONG CAYMAN LTD DDL 25445D101 $12.5M 3.08% 6,486,507 SH
6 NOAH HLDGS LTD NOAH 65487X102 $9.9M 2.44% 993,612 SH
7 BROADCOM INC AVGO 11135F101 $9.9M 2.43% 26,186 SH
8 BIRKENSTOCK HOLDING PLC BIRK M2029K104 $9.0M 2.22% 210,000 SH
9 ASTRAZENECA PLC AZN G0593M107 $9.0M 2.21% 48,088 SH
10 ALPHABET INC GOOG 02079K107 $8.7M 2.14% 24,592 SH
11 MERCK & CO INC MRK 58933Y105 $8.1M 2.00% 63,316 SH
12 APOGEE THERAPEUTICS INC APGE 03770N101 $7.7M 1.90% 58,314 SH
13 ABBVIE INC ABBV 00287Y109 $7.6M 1.86% 30,102 SH
14 JOHNSON & JOHNSON JNJ 478160104 $7.1M 1.74% 27,830 SH
15 YUM BRANDS INC YUM 988498101 $6.4M 1.57% 39,847 SH
16 PDD HOLDINGS INC PDD 722304102 $6.0M 1.47% 78,445 SH
17 COGENT BIOSCIENCES INC COGT 19240Q201 $6.0M 1.47% 154,220 SH
18 UBS GROUP AG UBS H42097107 $5.8M 1.43% 117,507 SH
19 NVIDIA CORPORATION NVDA 67066G104 $5.6M 1.39% 28,191 SH
20 IMMUNOVANT INC IMVT 45258J102 $5.6M 1.37% 144,671 SH
21 ARROWHEAD PHARMACEUTICALS IN ARWR 04280A100 $5.3M 1.30% 64,752 SH
22 IDEAYA BIOSCIENCES INC IDYA 45166A102 $5.2M 1.27% 138,708 SH
23 IQVIA HLDGS INC IQV 46266C105 $5.2M 1.27% 26,708 SH
24 H WORLD GROUP LTD HTHT 44332N106 $4.9M 1.21% 117,996 SH
25 VERA THERAPEUTICS INC VERA 92337R101 $4.9M 1.20% 113,687 SH
26 STRUCTURE THERAPEUTICS INC GPCR 86366E106 $4.8M 1.19% 90,363 SH
27 VISA INC V 92826C839 $4.8M 1.18% 14,000 SH
28 CATERPILLAR INC CAT 149123101 $4.8M 1.18% 4,500 SH
29 ROGERS COMMUNICATIONS INC RCI 775109200 $4.8M 1.18% 147,160 SH
30 AMER SPORTS INC AS G0260P102 $4.7M 1.16% 140,000 SH
31 KROGER CO KR 501044101 $4.5M 1.11% 81,305 SH
32 KLA CORP KLAC 482480100 $4.4M 1.08% 14,580 SH
33 CAMECO CORP CCJ 13321L108 $4.3M 1.06% 42,356 SH
34 ADVANCED MICRO DEVICES INC AMD 007903107 $4.2M 1.03% 7,210 SH
35 ARCUS BIOSCIENCES INC RCUS 03969F109 $4.1M 1.02% 134,217 SH
36 ADOBE INC ADBE 00724F101 $3.8M 0.94% 18,571 SH
37 FLOOR & DECOR HLDGS INC FND 339750101 $3.7M 0.91% 62,500 SH
38 META PLATFORMS INC META 30303M102 $3.7M 0.90% 6,500 SH
39 PALISADE BIO INC PALI 696389402 $3.6M 0.89% 1,730,866 SH
40 DUTCH BROS INC BROS 26701L100 $3.6M 0.88% 50,000 SH
41 FAIR ISAAC CORP FICO 303250104 $3.6M 0.88% 3,000 SH
42 GE VERNOVA INC GEV 36828A101 $3.6M 0.88% 3,047 SH
43 HOME DEPOT INC HD 437076102 $3.5M 0.87% 10,000 SH
44 VALARIS LTD VAL G9460G101 $3.3M 0.82% 45,956 SH
45 E L F BEAUTY INC ELF 26856L103 $3.3M 0.82% 45,000 SH
46 CAVA GROUP INC CAVA 148929102 $3.3M 0.81% 42,000 SH
47 DEFINIUM THERAPEUTICS INC DFTX 24477V105 $3.3M 0.81% 70,000 SH
48 ROIVANT SCIENCES LTD ROIV G76279101 $3.3M 0.80% 92,397 SH
49 TRANSUNION TRU 89400J107 $3.2M 0.79% 44,595 SH
50 REVOLUTION MEDICINES INC RVMD 76155X100 $3.2M 0.78% 16,994 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-13 $406.7M 85 0001256071-26-000007
2026-03-31 2026-05-14 $396.8M 89 0001256071-26-000005
2025-12-31 2026-02-13 $432.7M 124 0001256071-26-000004
2025-09-30 2025-11-13 $1.55B 120 0001256071-25-000009
Filer Information
Address
C/O PLATINUM ASSET MANAGEMENT
LEVEL 8, 7 MACQUARIE PLACE
SYDNEY AUSTRALIA 2000, C3 00000
Phone
61292557533
Filing Manager
PLATINUM INVESTMENT MANAGEMENT LTD
SYDNEY AUSTRALIA 2000, C3
Signatory
Jane Stewart
Chief Legal and Compliance Officer